Kenneth L. Dorsney Is Editor-In-Chief and Co-Author of a Second Edition of Premier ANDA Litigation Book
Morris James LLP would like to congratulate Partner Kenneth L. Dorsney as the editor-in-chief and co-author of a new book “ANDA Litigation: Strategies and Tactics for Pharmaceutical Patent Litigators, Second Edition”. Now updated and expanded, this Second Edition of ANDA Litigation: Strategies and Tactics for Pharmaceutical Patent Litigators is a comprehensive guide examining the intersection between the statutory and regulatory scheme governing approval of pharmaceuticals and U.S. patent law in the context of Paragraph IV ANDA litigation.. It offers an in-depth resource that balances perspectives from both name-brand drug makers and generic drug manufacturers. With a focus on current and developing law as well as practical strategies and tactics for litigation, it covers all steps in the litigation process. The book is available now for order online at The American Bar Association Store at shop.americanbar.org
Kenneth L. Dorsney is a registered patent attorney with nearly 18 years of experience litigating patent cases. Mr. Dorsney focuses his practice on the representation of corporate clients and the interests of outside counsel in patent cases pending before the U.S. District Court for the District of Delaware.